Annual Short Term Debt
$29.49 M
-$6.06 M-17.06%
September 30, 2024
Summary
- As of February 7, 2025, OTLK annual short term debt is $29.49 million, with the most recent change of -$6.06 million (-17.06%) on September 30, 2024.
- During the last 3 years, OTLK annual short term debt has risen by +$28.52 million (+2929.37%).
- OTLK annual short term debt is now -17.06% below its all-time high of $35.56 million, reached on September 30, 2023.
Performance
OTLK Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$29.49 M
-$2.97 M-9.16%
September 1, 2024
Summary
- As of February 7, 2025, OTLK quarterly short term debt is $29.49 million, with the most recent change of -$2.97 million (-9.16%) on September 1, 2024.
- Over the past year, OTLK quarterly short term debt has dropped by -$7.05 million (-19.30%).
- OTLK quarterly short term debt is now -34.09% below its all-time high of $44.74 million, reached on March 31, 2024.
Performance
OTLK Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
OTLK Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.1% | -19.3% |
| 3 y3 years | +2929.4% | +2929.4% |
| 5 y5 years | +155.8% | +96.4% |
OTLK Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.1% | +2929.4% | -34.1% | >+9999.0% |
| 5 y | 5-year | -17.1% | +2929.4% | -34.1% | >+9999.0% |
| alltime | all time | -17.1% | +2929.4% | -34.1% | >+9999.0% |
Outlook Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $29.49 M(-17.1%) | - |
| Sep 2024 | - | $29.49 M(-9.2%) |
| Jun 2024 | - | $32.46 M(-27.4%) |
| Mar 2024 | - | $44.74 M(+22.4%) |
| Dec 2023 | - | $36.55 M(+2.8%) |
| Sep 2023 | $35.56 M(+224.6%) | $35.56 M(+2.3%) |
| Jun 2023 | - | $34.74 M(+9.1%) |
| Mar 2023 | - | $31.84 M(>+9900.0%) |
| Dec 2022 | - | $27.70 K(-99.7%) |
| Sep 2022 | $10.95 M(+1025.2%) | $10.95 M(+4.2%) |
| Jun 2022 | - | $10.51 M(-54.0%) |
| Mar 2022 | - | $22.84 M(+78.7%) |
| Dec 2021 | - | $12.78 M(+1213.1%) |
| Sep 2021 | $973.50 K(-87.6%) | $973.50 K(-91.6%) |
| Jun 2021 | - | $11.62 M(+3.6%) |
| Mar 2021 | - | $11.21 M(+1786.9%) |
| Dec 2020 | - | $594.20 K(-92.4%) |
| Sep 2020 | $7.85 M | $7.85 M(-4.4%) |
| Jun 2020 | - | $8.21 M(-45.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $15.02 M(+35.6%) |
| Dec 2019 | - | $11.07 M(-4.0%) |
| Sep 2019 | $11.53 M(-37.3%) | $11.53 M(-0.3%) |
| Jun 2019 | - | $11.57 M(-10.4%) |
| Mar 2019 | - | $12.90 M(-10.7%) |
| Dec 2018 | - | $14.44 M(-21.4%) |
| Sep 2018 | $18.38 M(+267.1%) | $18.38 M(+0.8%) |
| Jun 2018 | - | $18.23 M(+0.9%) |
| Mar 2018 | - | $18.08 M(+6.2%) |
| Dec 2017 | - | $17.03 M(+240.2%) |
| Sep 2017 | $5.01 M(-18.9%) | $5.01 M(-70.2%) |
| Jun 2017 | - | $16.79 M(+38.3%) |
| Mar 2017 | - | $12.14 M(+13.8%) |
| Dec 2016 | - | $10.67 M(+72.8%) |
| Sep 2016 | $6.18 M(-61.0%) | $6.18 M(-2.0%) |
| Jun 2016 | - | $6.30 M(-44.3%) |
| Mar 2016 | - | $11.32 M(-3.7%) |
| Dec 2015 | - | $11.76 M(-25.7%) |
| Sep 2015 | $15.82 M(0.0%) | $15.82 M |
| Sep 2014 | $15.82 M | - |
FAQ
- What is Outlook Therapeutics annual short term debt?
- What is the all time high annual short term debt for Outlook Therapeutics?
- What is Outlook Therapeutics annual short term debt year-on-year change?
- What is Outlook Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Outlook Therapeutics?
- What is Outlook Therapeutics quarterly short term debt year-on-year change?
What is Outlook Therapeutics annual short term debt?
The current annual short term debt of OTLK is $29.49 M
What is the all time high annual short term debt for Outlook Therapeutics?
Outlook Therapeutics all-time high annual short term debt is $35.56 M
What is Outlook Therapeutics annual short term debt year-on-year change?
Over the past year, OTLK annual short term debt has changed by -$6.06 M (-17.06%)
What is Outlook Therapeutics quarterly short term debt?
The current quarterly short term debt of OTLK is $29.49 M
What is the all time high quarterly short term debt for Outlook Therapeutics?
Outlook Therapeutics all-time high quarterly short term debt is $44.74 M
What is Outlook Therapeutics quarterly short term debt year-on-year change?
Over the past year, OTLK quarterly short term debt has changed by -$7.05 M (-19.30%)